By: Jim Dunleavy Trainer King Leatherbury has been suspended 15 days and fined $500 by the Laurel Park board of stewards for a medication violation. Leatherbury's suspension began July 11 and continues through Monday. Classic Wildcat, trained by Leatherbury, won the third race at Laurel Park on April 22. Classic Wildcat tested positive for Mepivacaine
NEWS RELEASE November 15, 2012 Contact: Hallie Lewis (859) 224-2848 RMTC BOARD MAKES THERAPEUTIC WITHDRAWAL RECOMMENDATIONS, ANNOUNCES UPCOMING CORTICOSTEROIDS CONFERENCE At its November 13 meeting in Louisville, Kentucky, the Racing Medication and Testing Consortium (RMTC) board of directors addressed a number of important initiatives including therapeutic medications, laboratory proficiency, corticosteroid regulation and penalties for rule
NEWS RELEASE October 20, 2010 Contact: Hallie Lewis (859) 224-2848 RMTC MAKES THERAPEUTIC WITHDRAWAL TIME RECOMMENDATIONS, ANNOUNCES PROGRESS OF ITS DRUG TESTING INITIATIVES TASK FORCE Based on the recommendation of its Scientific Advisory Committee, the Racing Medication and Testing Consortium (RMTC) board of directors has recommended scientifically identified withdrawal guidelines and plasma thresholds for the
NEWS RELEASE October 1, 2009 Contact: Hallie Lewis (859) 224-2848 RMTC BOARD FORMS COMMITTEE TO OVERSEE IMPLEMENTATION OF DTI TASK FORCE RECOMMENDATIONS Moving forward with its initiative to significantly change the structure of drug testing in U.S. horse racing, the Racing Medication and Testing Consortium (RMTC) board of directors has approved the formation of a
NEWS RELEASE February 12, 2009 Contact: Hallie Roach (859) 224-2848 SCIENTIFIC ADVISORY COMMITTEE, DRUG TESTING TASK FORCE PROVIDE UPDATES TO RMTC BOARD At their February 6 meeting in Las Vegas, Nevada, the Racing Medication and Testing Consortium (RMTC) board of directors heard important updates from their Scientific Advisory Committee and Drug Testing Initiatives Task Force.
During its meeting on Thursday, November 2, in Louisville, Ky., the board of directors of the Racing Medication and Testing Consortium (RMTC) announced future plans regarding anabolic steroids and out-of-competition drug testing, and received an update on ongoing projects related to the development of withdrawal times for therapeutic medications. The RMTC also announced it has